The pathophysiology of bronchial asthma and targets for its drug treatment
- 1 June 1986
- journal article
- histamine and-kinins
- Published by Springer Nature in Inflammation Research
- Vol. 18 (3-4) , 281-287
- https://doi.org/10.1007/bf01964985
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Mast cell and histamine content of human bronchoalveolar lavage fluid.Thorax, 1985
- Relationship between Mediator Release from Human Lung Mast Cells in vitro and in vivoInternational Archives of Allergy and Immunology, 1985
- Mediators of Hypersensitivity and “Fog”‐Induced AsthmaAllergy, 1985
- Leukocyte Activation in Allergen-Induced Late-Phase Asthmatic ReactionsNew England Journal of Medicine, 1984
- The Bronchoconstrictor Effect of Inhaled Prostaglandin D2 in Normal and Asthmatic MenNew England Journal of Medicine, 1984
- Prevalence and spectrum of asthma in childhood.BMJ, 1983
- Exercise-induced release of histamine and neutrophil chemotactic factor in atopic asthmaticsJournal of Allergy and Clinical Immunology, 1982
- IDENTIFICATION BY IMMUNOFLUORESCENCE OF EOSINOPHIL GRANULE MAJOR BASIC PROTEIN IN LUNG TISSUES OF PATIENTS WITH BRONCHIAL ASTHMAThe Lancet, 1982
- Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytesNature, 1980
- INHIBITORY EFFECTS OF DISODIUM CROMOGLYCATE ON ALLERGEN-INHALATION TESTSThe Lancet, 1968